This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative. Three areas to be discussed are: new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
Learn about new incentives (existing and proposed) to create a business case for patient safety.
Learn about failings of error reporting regimes.
Learn about engaged surveillance.